iTonic Holdings (ITOC) Equity Ratio (2023 - 2025)

iTonic Holdings recorded quarterly Equity Ratio of 0.89 in Q4 2025, down 2.88% quarter-over-quarter from 0.92 in Q4 2024, and down 2.88% year-over-year from 0.92 in Q4 2024.

iTonic Holdings' Equity Ratio history runs 3 years deep, the most recent figure standing at 0.89 for Q4 2025.

  • In Q4 2025, Equity Ratio fell 2.88% year-over-year to 0.89; the TTM figure through Dec 2025 stood at 0.89 (down 2.88% YoY), while the FY2025 annual figure was 0.89, down 2.88% from the prior year.
  • Equity Ratio came in at 0.89 for Q4 2025 at iTonic Holdings, down from 0.92 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.92 in Q4 2024 to a low of 0.19 in Q4 2023.
  • A 3-year average of 0.67 and a median of 0.89 in 2025 frame the typical range for Equity Ratio.
  • Across the five-year window, Equity Ratio jumped 385.56% in 2024 and retreated 2.88% in 2025, its largest moves.
  • iTonic Holdings' Equity Ratio stood at 0.19 in 2023, then surged by 385.56% to 0.92 in 2024, then fell by 2.88% to 0.89 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods registered 0.89, 0.92, and 0.19 for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 iTonic Holdings 4.81 Mn 3.89 Mn - 0.89

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.89
Dec 31, 2024 0.92
Dec 31, 2023 0.19